Showing 1 - 8 results of 8 for search 'Steven L Allen', query time: 0.04s Refine Results
  1. 1
    Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis

    Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis by Ruby Sharma, Alla Keyzner, Johnson Liu, Thomas Bradley, Steven L. Allen

    Published 2015-01-01
    Get full text
    Article
  2. 2
    A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice

    A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice by Piers E. M. Patten, Piers E. M. Patten, Gerardo Ferrer, Shih-Shih Chen, Jonathan E. Kolitz, Jonathan E. Kolitz, Kanti R. Rai, Kanti R. Rai, Steven L. Allen, Steven L. Allen, Jacqueline C. Barrientos, Jacqueline C. Barrientos, Nikolaos Ioannou, Alan G. Ramsay, Nicholas Chiorazzi, Nicholas Chiorazzi, Nicholas Chiorazzi

    Published 2021-03-01
    Get full text
    Article
  3. 3
    Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation

    Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation by Rosa Catera, Yun Liu, Chao Gao, Xiao-Jie Yan, Amanda Magli, Steven L. Allen, Jonathan E. Kolitz, Kanti R. Rai, Charles C. Chu, Ten Feizi, Kostas Stamatopoulos, Nicholas Chiorazzi

    Published 2017-01-01
    Get full text
    Article
  4. 4
    Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course

    Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course by Davide Bagnara, Davide Bagnara, Catherine Tang, Jennifer R. Brown, Siddha Kasar, Stacey Fernandes, Monica Colombo, Stefano Vergani, Andrea N. Mazzarello, Fabio Ghiotto, Fabio Ghiotto, Silvia Bruno, Fortunato Morabito, Fortunato Morabito, Kanti R. Rai, Kanti R. Rai, Jonathan E. Kolitz, Jonathan E. Kolitz, Jacqueline C. Barrientos, Jacqueline C. Barrientos, Steven L. Allen, Steven L. Allen, Franco Fais, Franco Fais, Matthew D. Scharff, Thomas MacCarthy, Nicholas Chiorazzi, Nicholas Chiorazzi

    Published 2021-05-01
    Get full text
    Article
  5. 5
    Activated CLL cells regulate IL-17F–producing Th17 cells in miR155-dependent and outcome-specific manners

    Activated CLL cells regulate IL-17F–producing Th17 cells in miR155-dependent and outcome-specific manners by Byeongho Jung, Gerardo Ferrer, Pui Yan Chiu, Rukhsana Aslam, Anita Ng, Florencia Palacios, Michael Wysota, Martina Cardillo, Jonathan E. Kolitz, Steven L. Allen, Jacqueline C. Barrientos, Kanti R. Rai, Nicholas Chiorazzi, Barbara Sherry

    Published 2022-06-01
    Get full text
    Article
  6. 6
    Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli

    Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli by Andrea N. Mazzarello, Mark Fitch, Martina Cardillo, Anita Ng, Sabreen Bhuiya, Esha Sharma, Davide Bagnara, Jonathan E. Kolitz, Jacqueline C. Barrientos, Steven L. Allen, Kanti R. Rai, Joanna Rhodes, Marc K. Hellerstein, Nicholas Chiorazzi

    Published 2023-09-01
    Get full text
    Article
  7. 7
    Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

    Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia by Matthew Kaufman, Xiao-Jie Yan, Wentian Li, Emanuela M. Ghia, Anton W. Langerak, Laura Z. Rassenti, Chrysoula Belessi, Neil E. Kay, Frederic Davi, John C. Byrd, Sarka Pospisilova, Jennifer R. Brown, Mark Catherwood, Zadie Davis, David Oscier, Marco Montillo, Livio Trentin, Richard Rosenquist, Paolo Ghia, Jacqueline C. Barrientos, Jacqueline C. Barrientos, Jacqueline C. Barrientos, Jacqueline C. Barrientos, Jonathan E. Kolitz, Jonathan E. Kolitz, Steven L. Allen, Steven L. Allen, Kanti R. Rai, Kanti R. Rai, Kanti R. Rai, Kanti R. Rai, Kostas Stamatopoulos, Thomas J. Kipps, Donna Neuberg, Nicholas Chiorazzi, Nicholas Chiorazzi, Nicholas Chiorazzi, Nicholas Chiorazzi

    Published 2022-07-01
    Get full text
    Article
  8. 8
    IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.

    IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria. by Kwan-Ki Hwang, Ashley M Trama, Daniel M Kozink, Xi Chen, Kevin Wiehe, Abby J Cooper, Shi-Mao Xia, Minyue Wang, Dawn J Marshall, John Whitesides, Munir Alam, Georgia D Tomaras, Steven L Allen, Kanti R Rai, Jane McKeating, Rosa Catera, Xiao-Jie Yan, Charles C Chu, Garnett Kelsoe, Hua-Xin Liao, Nicholas Chiorazzi, Barton F Haynes

    Published 2014-01-01
    Get full text
    Article

Search Tools: